Admitting that this is an exploratory study, the data provided by the study may be potentially useful for the planning of future research and for the comparison with other studies' results. However, in its present form, the paper does not exploit this potential since it presents mostly figures, report only a few numerical results, and some of the reported numbers are incomplete. In addition, the control sample is not described and the procedures for the administration of the scales to this sample are not described either. There are also some apparent inconsistencies between some of the numbers reported which need to be corrected or justified, as explained below.
Apparent inconsistencies:
1) Page 2 reports that "53 patients filled the criteria". However, Figure 1 reports "64 patients fulfilled the criteria". Please clarify or correct this.
2) Page 12 reports that "2 women had schizophrenia diagnoses". But Table 1 reports only one woman with this diagnosis. Please correct or clarify.
3) Page 12 describes that "a domain score 5 is defined as dependence". But then describes "ADL dependence is defined as a Motor score 77 and a social cognitive score 29". The latter definition is inconsistent with the former one. According to the former one, the cutoff for motor score should be 5x13=65, and the cutoff for social cognitive score should be 5x5=25, because there are 13 and 5 subscales respectively. Please revise or modify the analyses so that they are consistent with the published cutoff of 5.
Suggestions:
1) Please provide sample sizes in methods section. For instance, in page 7. Not just in the abstract.
2) Please clarify the sentence: page 8, lines 14-19. The term "predict" seems to be used incorrectly.
3) Page 8, line 56. Please define ICF. 4) Page 11. Please describe procedures for the control group (the group used in Figure 2 7) Please include tables providing numerical descriptives for the 3 scales and their subscales (means, SDs, or medians, percentages, frequencies, etc). I think these tables will be much more useful for future researchers than the figures. The tables must also include the descriptives for the controls if applicable with p-values comparing the groups. SDs will be useful for powering future studies. Fortunately, online publications do not have space limitations and this is an opportunity that has to be taken to provide a more complete and useful report. 8) Please clarify the sentence lines 23-24, page 13. Unclear what "overestimating their capacity" means. 9) Please provide a table describing the original FrSBe scores and their subscales (not the normalized scores). The original scores may be much more useful than the normalized scores because the t scores assume the Swedish sample is comparable to US population, which may be debatable. Anyway, future researchers may want to compare their data with less processed numbers or may want to power their study based on original scores.
Other minor corrections: 9) Please add "year" units to Table 1 
GENERAL COMMENTS
This manuscript is about detecting cognitive impairment in schizophrenia patients using 1 screening measure and 2 rating scales. All the tools used in this study are well known. The study is interesting and it could be helpful in its purpose. However I found several weak point that need to be addressed.
1) The main goal does not adjust to reality. If the authors are using screening measures and scales it is not appropriate to say they detected cognitive impairment. In order to do this a comprehensive neuropsychological assessment is needed by areas or domains. They found possible cognitive impairment that needs further analysis and assessment. This should be clear in the whole text and title.
2) There is no information on medication and nothing in the text about its possible implications in the results or symptoms 3) They should put statistics tables in a more clear format. Table for correlations, descriptive values, etc. 4) They should mention the medication fact in the limitations.
VERSION 1 -AUTHOR RESPONSE
Dr Diaz:
Answers to Apparent inconsistences: 1) Page 2: the number 53 is replaced by 64. Further, the gender distribution of the sample was wrong and has been corrected. The correct numbers are 14 males and 5 females. 2) Figure 1 , the flow chart, has been moved to the Procedure section, page 12. Demographic data are shown as a new Table 1 in the Results section. Two is the correct number of women with schizophrenia diagnoses. The number has been corrected in the former Table 1, now  Table 2. 3) The procedure for compilation of the FIM® ADL dependence scores is described on page 11, lines 11-20.
Answers to Suggestions 1. The sample sizes of the participating patients and the control group are mentioned on page 8, lines 18-19. 2. The word "predict" has been changed to "estimate". 3. ICF is defined on page 9, lines 18-19. 4. The characteristics and procedure for the BNIS control group are described on page 8, lines
19-24, and page 9, lines 1-4. 5. A Table 3 , reporting the results for the participant group and the control group has been provided. 6. Diagnoses for males have been added in upper panel of Table 6 . 8. On page 9, line 9-13, the BNIS item Self awareness of memory performance and its scoring principle are explained, and the formulation on page 13 (now 14) you asked about has been changed accordingly. 9. Se point 7 above.
Answers to Minor corrections 10. Year units are added in Table 1 . 11. Md is defined in the Statistics section on page 13, line 3. 12. Figure 4 has been removed and has been replaced by table 5.
Answers to comments by the reviewers Dr De la Torre 1. The following formulations have been modified in order to meet the demands of accurate definitions characterizing the assessment methods:
In the Conclusions section of the Abstract, line 1, the words "Indications of " have been added, and on line 2, the word "tentative" has been added.
In the Introduction section on page 6, line7, formulations about cognitive screening have been changed.
In the Discussion paragraph, the word "possible" has been added on page 16, line 12, on page 17, lines 4 and 17, on page 18 line 12
On page 19, line 2 the words "assessed as" have been added, and on line 19 the words "for possible cognitive difficulties".
On page 20 line 7, the words "basic" and "possible" have been added.
2. From a clinical practical perspective, the disturbances we found deserved attention in their own right. The communication with the patients and the demands put on them by all staff needed to be changed in order to adjust to their actual capacity. However, from a general diagnostic and scientific perspective, it is of course very important to gather and analyze medication data. Also, data about comorbidity and brain scanning data may contribute to the understanding of the causes of the disturbances. This work would have required a psychiatrist. Unfortunately, no psychiatrist was available to do this, neither during the data collection period nor at the present time. In order to give at least some medication data, basic information about antipsychotic drug ordinations from the first assessment date for each patient has now been collected from the patients´ charts by their case managers. These data are reported in the Results section and can be found on page 13, lines 16-21. Further, the lack of data on medication, comorbidity and brain scanning are mentioned in the Strengths and Limitations section on page 4, and also in the last paragraph of the Discussion on page 20 concerning suggested further research.
3. Following suggestions from you and the other reviewer, tables of descriptive data have been provided for the 3 measurements, adding important information. 
VERSION 2 -REVIEW REVIEWER

GENERAL COMMENTS
This paper is about a comprehensive screening assessment of neuropsychological symptoms in patients within the psychosis spectrum disorder.
The main idea of the paper is very interesting and helpful for the research and clinical work in this field. However some weak points were detected that need to be reviewed before it can be accepted for publication.
1) One very important and basic question I have about the goal of this paper is:
Why is this strategy helpful? it should be clearly stated in the paper why authors consider this approach is better than other existing ones. Why should we use this BNIS over the Mini Mental? Maybe the authors have it clear but some readers may not.
2) The size of the sample is quite small but authors pointed to this in the limitations section. The first group is much bigger than the other two.
3) Authors mention that general level of consciousness was measured before the assessment. How was this measure done? 4) There is an important question about the participants. I could not see any specific reference to the ethics aspects, participation of patients, consents, etc. This should be reviewed and clearly stated in the paper. The Section materials and Methods, why not participants, materials and methods? 5) Line 3 in Discussion says" possible considerable cognitive dysfunction". There was or there was not? possible is not a good word in this case. 6) Some sentences are obvious and they do not represent findings of this study but facts very well known in the research of this field. Saying the executive deficits are due to frontal lobes is not new and references should be added or better explained. 7) Other some minor points: There is not consistency in the use of decimals, sometimes there is 0 before and sometimes not. Tables are not in the correct format.
8) The study would be better if the disease symptoms were classified and groups also divided by this aspect. A larger sample would also help of course. Medication may be playing a big role in these neurocognitive symptoms.
Reviewing these aspects may improve the paper. The Ethics aspect is the most important of them.
VERSION 2 -AUTHOR RESPONSE
Answers to comments by reviewer Prof. Dr. Gabriel G. De la Torre 1. Among the variety of short assessment methods for cognition, the RBANS, Cognistat, formerly NCSE, and MMSE (Mini Mental) have all been translated to Swedish and adapted to Swedish populations. They were excluded from this study because they are mainly intended for dementia and used in geriatrics and elder care. The BACS is designed for schizophrenia but was excluded because it has not been translated into Swedish. BNIS, on the other hand, is a psychometrically well investigated instrument that is translated into Swedish and has Swedish norms. BNIS has been used in Sweden for many years, both in research and clinical work, however not in psychiatry. BNIS was constructed to measure higher cerebral functions irrespective of diagnosis which in contrast to MMSE, which is constructed to differentiate between depression and dementia. It contains simple items from different relevant cognitive areas. 2. It is not clear to us what you mean. We hope that the uncertainty of group sizes that you ask about refers to an earlier formulation in the abstract. This has now been corrected in the Participants paragraph of the Abstract. As a compensation for the small group, Table 2 shows comparisons between participant and non-participant patients from the unit where the study was made, and all patients from Sahlgrenska university hospital register who had ICD diagnoses F20 or F25 2014. Are you referring to the latter group being bigger? 3. In the paragraph about of BNIS in the manuscript this is descrbed as a pre-screen. This includes general consciousness/wakefulness, basic language function and level of collaboration. 4. This is written in the text under Procedure in the Methods section, however in 2 parts. The study has received ethical approval from the Regional Ethical Review Board in Gothenburg, number 704-10. All patients were given oral and written information about the study by their case managers and gave written consent to participate in the study, and to the publication of data collected about them. The data collection for each patient started within 2 weeks after the date of written consent and was completed within a 3 week interval. All this was done according to the ethical approval. 5. The wording was changed since you correctly pointed that a screen is not the same as a comprehensive neuropsychological assessment and therefore the results can't be as certain. 6. The reason commenting on frontal problems in this population is the fact that we have used a tool for assessing frontal dysfunction. We believe this is well described in the introduction as well as in the methods section and the discussion. 7. Thank you for observing this. We have made corrections twice in the manuscript as well as in table 6. 8. We agree that a larger study would be beneficial. Your comments regarding medication were addressed in the previous revision. A matching of psychosis symptoms and medication with the results could be addressed in another study. Also, data about comorbidity and brain scanning data may contribute to the understanding of the causes of the disturbances. This work would have required a psychiatrist. Unfortunately, no psychiatrist was available to do this, neither during the data collection period nor at the present time.
In order to give at least some medication data, basic information about antipsychotic drug ordinations from the first assessment date for each patient has now been collected from the patients´ charts by their case managers. These data are reported in the Results section and can be found on page 13, lines 16-21. Further, the lack of data on medication, comorbidity and brain scanning are mentioned in the Strengths and Limitations section on page 4, and also in the last paragraph of the Discussion on page 20 concerning suggested further research. 
GENERAL COMMENTS
This a better version of the paper. Some issues have been addressed and everything is more clear and straightforward. However Tables are not in correct format and they in different styles. Decimals used also differ. Consistency in these aspects are important and without reviewing these aspects paper should not be published.
VERSION 3 -AUTHOR RESPONSE
The tables have now been revised and placed in the article text following Dr de la Torres´ suggestions and BMJ directions. We hope this is to your satisfaction.
